Archives
-
Estradiol Benzoate: From Receptor Signal to Translation
2026-08-24
A mechanistic and translational guide to using Estradiol Benzoate as an estrogen receptor alpha agonist, with practical assay design, quality considerations, and lessons from structure-based NSP15 inhibitor screening.
-
REV1–DHX36 Control of G-Quadruplex Replication
2026-08-24
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings establish a two-tier mechanism for G4 tolerance and clarify how loss of REV1 reshapes replication, mutagenesis, and ATM/ATR DNA damage response signaling.
-
Dual Luciferase Reporter Gene System Guide
2026-08-23
The Dual Luciferase Reporter Gene System pairs firefly and Renilla signals to distinguish true promoter effects from sample-to-sample variation. This guide translates the system into practical promoter-mapping, transcription-factor, and high-throughput workflows, with troubleshooting informed by a recent tomato aluminium-tolerance study.
-
HDAC Inhibition Reverses EBV-Driven NPC Dedifferentiation
2026-08-22
The reference study identifies an epigenetic mechanism by which EBV latent membrane protein 1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. It shows that HDAC inhibition can restore CEBPA expression and partially reverse this state in cellular and mouse xenograft models, providing a mechanistic rationale for differentiation-oriented treatment of a solid tumor.
-
Elobixibat Hydrate: Mechanism-to-Assay Guide
2026-08-22
Elobixibat hydrate is an ileal bile acid transporter inhibitor whose effects are best understood through a layered assay strategy rather than a single endpoint. This guide connects IBAT pharmacology with orthogonal transporter, signaling, tissue, and translational readouts while extracting practical assay lessons from a mechanistic receptor study.
-
EdU Flow Cytometry Assay Kits (Cy5) in CRC
2026-08-21
EdU Flow Cytometry Assay Kits (Cy5) provide a practical way to quantify S-phase DNA synthesis while preserving cells for cell-cycle and immune-marker analysis. This article shows how to apply the assay to colorectal cancer models, diet-immunotherapy studies, pharmacodynamic testing, and troubleshooting-heavy flow cytometry workflows.
-
Flumequine: DNA Topoisomerase II Inhibitor
2026-08-20
Flumequine is a synthetic small-molecule DNA topoisomerase II inhibitor used for enzyme inhibition, DNA replication research, and drug-response studies. The B2292 material is reported at greater than 98% purity, with an approximate vendor-reported IC50 of 15 μM under the listed assay conditions.
-
Geneticin: G418 Sulfate Selection Workflows
2026-08-20
Geneticin, G418 Sulfate enables reproducible enrichment of neomycin-resistant cells while supporting carefully controlled antiviral experiments. This guide connects practical selection workflows with the macrophage EV–miR-660 breast cancer model, highlighting assay design, optimization, and cross-domain limitations.
-
GSH and GSSG Assay Kit in Tumor Redox Biology
2026-08-19
Discover how the GSH and GSSG Assay Kit converts tumor hypoxia and immunometabolic questions into measurable redox endpoints. This practical framework explains assay selection, sample handling, interpretation, and the limits of bulk glutathione measurements.
-
G-Quadruplexes Modulate TDP-43 Condensation and Toxicity
2026-08-19
Oldani et al. show that RNA G-quadruplexes directly influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical and cellular models. The study supports a structure-centered view of TDP-43 pathology in which modulating G-quadruplex stability may alter stress-associated condensates and disease-relevant cell injury.
-
Cyclophosphamide: From Mechanism to Translational Impact
2026-08-18
A strategic guide to using Cyclophosphamide in cancer research, immune modulation, and translational workflows by connecting hepatic activation, DNA cross-linking, apoptosis, model selection, and clinical relevance.
-
CTP Solution (100 mM) for RNA Synthesis
2026-08-18
CTP Solution (100 mM) provides Cytidine-5'-triphosphate for in vitro transcription, RNA amplification, and related biochemical workflows. The K1045 formulation is an aqueous, HPLC-pure nucleotide solution with defined pH and contamination controls, but it does not by itself establish therapeutic activity in mRNA-LNP cancer studies.
-
Candida krusei Apoptosis in Bovine Mammary Cells
2026-08-17
This study shows that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial-cell apoptosis through different dominant routes: mitochondrial signaling for the yeast phase and death ligand/receptor signaling for the hypha phase. Its phase-resolved co-culture design connects fungal morphology with TLR-associated MAPK responses, offering a useful framework for apoptosis assay development and mastitis research.
-
PtrbZIP12 Links Phosphorylation to Poplar Drought Tolerance
2026-08-17
The reference study identifies PtrbZIP12 as a positive regulator of drought resistance in Populus trichocarpa and demonstrates that it directly activates PtrDHN and PtrPOD. By connecting transcriptional control with phosphorylation-dependent regulation, the work provides a mechanistic framework for studying stress-responsive signal transduction in trees.
-
HLTP1 Targets JNK in Hepatic Ischemia-Reperfusion Injury
2026-08-16
This study identifies human liver transplantation peptide 1 (HLTP1) through peptidomic analysis of human transplant samples and shows that it attenuates hepatic ischemia-reperfusion injury by suppressing JNK phosphorylation and hepatocyte apoptosis. The work connects human-derived peptide discovery with mechanistic validation in animal and cell models, while highlighting the need for further pharmacological and translational studies.